About
Hardy holds a B.A. in Land Economy from the University of Cambridge and an M.B.A. from the University of Michigan Ross School of Business. His early career included leadership roles at Novartis and Genentech. At Roche he led Asia Pacific for Roche Pharma from May 2014 to August 2016 and global product strategy from August 2016 to March 2019. He then became Chief Executive Officer of Genentech in May 2019. Other biotech and pharmaceutical chief executives with pages on Whoo include Reshma Kewalramani of Vertex Pharmaceuticals and Yvonne Greenstreet of Alnylam Pharmaceuticals.
In BioMarin's third-quarter 2026 results release he is quoted as President and Chief Executive Officer.
Whoo compiled this page from public sources: BioMarin 2026 proxy statement (SEC), BioMarin Q3 2026 results filing (SEC), Wikipedia: BioMarin Pharmaceutical. It is not affiliated with or endorsed by Alexander Hardy. Are you Alexander Hardy? Claim this page, or write to [email protected] to correct or remove it. Last updated: 2026-11-18.
Want a page like this? Create yours from your résumé.
Experience
President and Chief Executive Officer — BioMarin Pharmaceutical
December 2023 – Present | San Rafael, California
- Leads the company and serves on its board
- Nearly 20 years at Genentech and Roche in total
Chief Executive Officer — Genentech
May 2019
Head of Global Product Strategy — Roche
August 2016 – March 2019
Head, Asia Pacific, Roche Pharma — Roche
May 2014 – August 2016